These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 39116570)
1. Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram. Jia Z; Xing H; Wang J; Wang X; Wang X; Liu C; He J; Wu S; Miao J; Liu H; Liu Y Pathol Res Pract; 2024 Sep; 261():155504. PubMed ID: 39116570 [TBL] [Abstract][Full Text] [Related]
2. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study. Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583 [TBL] [Abstract][Full Text] [Related]
3. Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction. Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531 [TBL] [Abstract][Full Text] [Related]
4. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy. Yang W; Yang Y; Zhang C; Yin Q; Zhang N Magn Reson Imaging; 2024 Sep; 111():120-130. PubMed ID: 38703971 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study. Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825 [TBL] [Abstract][Full Text] [Related]
6. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J Front Immunol; 2022; 13():831848. PubMed ID: 35320931 [TBL] [Abstract][Full Text] [Related]
7. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer. Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939 [TBL] [Abstract][Full Text] [Related]
8. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus. Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400 [TBL] [Abstract][Full Text] [Related]
9. Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort. Luo C; Zhong X; Wang Z; Wang Y; Wang Y; He P; Peng Q; Zheng H Int J Biol Markers; 2019 Mar; 34(1):41-46. PubMed ID: 30852974 [TBL] [Abstract][Full Text] [Related]
10. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection]. Su J; Wang X; Sun Z Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796 [No Abstract] [Full Text] [Related]
12. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model]. Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613 [No Abstract] [Full Text] [Related]
13. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients. Wu N Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Nomogram for Predicting Survival Based on Ferritin and Transferrin Ratio in Breast Cancer Patients. Huang S; Lai H; Pan X; Lin Q; Qin Y; Liu F; Fang M; Huang W; Wei C Cancer Control; 2024; 31():10732748241261553. PubMed ID: 38850515 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy. Yang X; Rao J; Yang W; Shui R Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy. Lai J; Pan Z; Chen P; Ye G; Chen K; Su F Jpn J Clin Oncol; 2019 Jan; 49(1):22-28. PubMed ID: 30508184 [TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting outcomes in elderly women with mucinous breast cancer: A retrospective study combined with external validation in southwest China. Zhang Z; Zhanghuang C; Cai Q; Song G; Wang Q; Tang Y; Li H Cancer Rep (Hoboken); 2024 Jul; 7(7):e2112. PubMed ID: 39051553 [TBL] [Abstract][Full Text] [Related]
18. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study. Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640 [TBL] [Abstract][Full Text] [Related]
19. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients. Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273 [TBL] [Abstract][Full Text] [Related]
20. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases. Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]